Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Wellness
Home & Realty
Outdoor Guide
Women
Class of 2023
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Gossamer Bio, Inc.
Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs
Today 16:08 EDT
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio to Present Results of TORREY FRI Sub-Study at the European Respiratory Society International Congress 2023
September 07, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update
August 08, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio to Hold Conference Call with PAH Experts to Discuss PROSERA Phase 3 Design and Interim TORREY OLE Results
July 24, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces $212 Million Private Placement Financing
July 20, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces TORREY Data to be Featured at American Thoracic Society 2023 International Conference
May 18, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update
May 09, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update
March 17, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces Seralutinib Meets Primary Endpoint in Phase 2 TORREY Study in PAH
December 06, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update
November 03, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update
August 09, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces $120 Million Private Placement Financing
July 13, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces Publication of Key Preclinical Data in the European Respiratory Journal Highlighting Seralutinib’s Potential for the Treatment of PAH
June 09, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces First Quarter 2022 Financial Results and Provides Business Update
May 10, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces GB004 Topline Results from Phase 2 SHIFT-UC Study in Ulcerative Colitis and Provides Corporate Update
April 25, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio to Announce Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call and Webcast on March 3, 2022
February 28, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 08, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 8, 2021
November 02, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces Addition of Two CNS-Penetrant BTK Inhibitors to its Product Candidate Pipeline: GB5121 & GB7208
October 11, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio to Host Webcast Announcing its Next Clinical Product Candidates on October 11, 2021
October 07, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces Appointment of Bryan Giraudo as Chief Operating Officer, in addition to Chief Financial Officer Role
September 21, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
August 09, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021
August 02, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces GB004 Clinical Trial Data Presentations at 2021 Virtual Congress of the European Crohn’s and Colitis Organisation
July 07, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces Promotion of Richard Aranda, M.D., to Chief Medical Officer
June 21, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
May 06, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces Executive Management Transition and Promotion of Laura Carter, Ph.D., to Chief Scientific Officer
April 20, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Gossamer Bio Announces Promotion of Caryn Peterson to Executive Vice President, Regulatory Affairs
April 16, 2021
From
Gossamer Bio, Inc.
Via
Business Wire
Tickers
GOSS
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.